Gil Blum
Stock Analyst at Needham
(4.16)
# 661
Out of 5,182 analysts
433
Total ratings
43.66%
Success rate
17.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma | Initiates: Buy | $44 | $21.48 | +104.89% | 1 | Apr 10, 2026 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.48 | +575.68% | 36 | Apr 9, 2026 | |
| ABSI Absci | Reiterates: Buy | $7 | $4.86 | +44.03% | 10 | Mar 30, 2026 | |
| CELC Celcuity | Reiterates: Buy | $122 | $120.07 | +1.61% | 24 | Mar 26, 2026 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $18 | $9.07 | +98.46% | 8 | Mar 11, 2026 | |
| IMCR Immunocore Holdings | Maintains: Buy | $71 → $75 | $28.79 | +160.51% | 15 | Feb 26, 2026 | |
| ACLX Arcellx | Downgrades: Hold | n/a | $115.07 | - | 26 | Feb 23, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $80 → $82 | $52.06 | +57.51% | 28 | Feb 13, 2026 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $5 → $3 | $0.28 | +977.97% | 21 | Jan 13, 2026 | |
| GERN Geron | Reiterates: Buy | $6 | $1.51 | +297.35% | 23 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $17.08 | +52.22% | 31 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $2.77 | +297.11% | 19 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $21.07 | - | 39 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.45 | +155.03% | 4 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $6.30 | +90.48% | 33 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $6.80 | +517.65% | 17 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.41 | +134.60% | 26 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.49 | - | 8 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $6 | $1.26 | +376.19% | 8 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.30 | - | 9 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.43 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.53 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $9.25 | +418.92% | 9 | Aug 2, 2024 |
Lyell Immunopharma
Apr 10, 2026
Initiates: Buy
Price Target: $44
Current: $21.48
Upside: +104.89%
Autolus Therapeutics
Apr 9, 2026
Reiterates: Buy
Price Target: $10
Current: $1.48
Upside: +575.68%
Absci
Mar 30, 2026
Reiterates: Buy
Price Target: $7
Current: $4.86
Upside: +44.03%
Celcuity
Mar 26, 2026
Reiterates: Buy
Price Target: $122
Current: $120.07
Upside: +1.61%
Artiva Biotherapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $18
Current: $9.07
Upside: +98.46%
Immunocore Holdings
Feb 26, 2026
Maintains: Buy
Price Target: $71 → $75
Current: $28.79
Upside: +160.51%
Arcellx
Feb 23, 2026
Downgrades: Hold
Price Target: n/a
Current: $115.07
Upside: -
CRISPR Therapeutics AG
Feb 13, 2026
Maintains: Buy
Price Target: $80 → $82
Current: $52.06
Upside: +57.51%
Mereo BioPharma Group
Jan 13, 2026
Maintains: Buy
Price Target: $5 → $3
Current: $0.28
Upside: +977.97%
Geron
Aug 9, 2024
Reiterates: Buy
Price Target: $6
Current: $1.51
Upside: +297.35%
Apr 23, 2026
Reiterates: Buy
Price Target: $26
Current: $17.08
Upside: +52.22%
Mar 26, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $2.77
Upside: +297.11%
Mar 26, 2026
Reiterates: Underperform
Price Target: n/a
Current: $21.07
Upside: -
Mar 20, 2026
Reiterates: Buy
Price Target: $19
Current: $7.45
Upside: +155.03%
Mar 19, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.30
Upside: +90.48%
Mar 9, 2026
Reiterates: Buy
Price Target: $42
Current: $6.80
Upside: +517.65%
Feb 26, 2026
Reiterates: Buy
Price Target: $8
Current: $3.41
Upside: +134.60%
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.49
Upside: -
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.26
Upside: +376.19%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.30
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.43
Upside: -
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.53
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $9.25
Upside: +418.92%